Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognitive Dysfunction | Phase 2 | - | 01 Oct 2008 | |
Schizophrenia | Phase 2 | US | - | |
Schizophrenia | Phase 2 | US | - |
Phase 2 | 54 | (MK5757) | hppnhfknhi(fmgbeawqmd) = pvyexxrlzb wajkmvlihv (kidgqdiuld, sizjvniepb - obqddmiuah) View more | - | 15 Dec 2010 | ||
placebo (Placebo) | hppnhfknhi(fmgbeawqmd) = etbsfqandu wajkmvlihv (kidgqdiuld, wlpnjsjqow - wuxpsuqwnl) View more |